Anyone have any background on Eventus Advisors?Lets hope it is not a subsidiary of Droxford like the last rights issue or this is a takeover without having to pay the usual premium!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025